PI3K Inhibitors Archives - Metastatic Breast Cancer Trial Talk

PI3K Inhibitors

New FDA Approval: A PI3K Inhibitor

The U.S. Food and Drug Administration (FDA) approved Piqray® for treating advanced breast cancer. Use the links below to learn more about the FDA approval and how PI3K inhibitors work and to find clinical trials on Metastatic Trial Search for Piqray and other therapies being tested in patients whose tumors have a PIK3CA mutation.

Read More


for past articles or specific information.